| ACHD | Adults with Congenital Heart Disease |
| ATB | Antithrombotic Therapy |
| BMI | Body Mass Index |
| CHD | Congenital Heart Disease |
| DILV | Double Inlet Left Ventricle |
| ETA | Endothelin Antagonist |
| Ebstein | Ebstein’s Anomaly |
| GLIM | Global Leadership Initiative on Malnutrition |
| GPP | Good Pharmacoepidemiological Practice |
| HF | Heart Failure |
| HLHS | Hypoplastic Left Heart Syndrome |
| IL-1 | Interleukin-1 |
| IL-6 | Interleukin-6 |
| MBW | Metabolic Body Weight |
| MRA | Mineralocorticoid Receptor Antagonist |
| PA-VSD | Pulmonary Atresia with Ventricular Septal Defect |
| PA-intact VSD | Pulmonary Atresia with Intact Ventricular Septum |
| PDE5-I | Phosphodiesterase-5 Inhibitor |
| PI | Pulmonary Insufficiency |
| PuR | Pulmonary Regurgitation |
| RAAS | Renin–Angiotensin–Aldosterone System |
| SARMs | Selective Androgen Receptor Modulators |
| SGLT2-I | Sodium-Glucose Cotransporter 2 Inhibitor |
| SNS | Sympathetic Nervous System |
| SPSS | Statistical Package for the Social Sciences |
| TGA | Transposition of the Great Arteries |
| TNF-α | Tumor Necrosis Factor Alpha |
| TOF | Tetralogy of Fallot |
| TrA | Truncus Arteriosus Communis |
| UVH | Univentricular Heart |
| VSD | Ventricular Septal Defect |
| ccTGA | Congenitally Corrected Transposition of the Great Arteries |
| sGC-stimulator | Soluble Guanylate Cyclase Stimulator |